PRMT1 and neuroblastoma: In neuroblastomas with MYCN amplification or high MYCN levels without MYCN amplification, the positive regulatory loop of the MYCN-PRMT1 axis may promote a MYCN-driven oncogenic program3,6 whereas PRMT1-mediated activation of ATF5 may lead to enhanced survival.